Study | Patient selection | Dosage | Type | Qualified supervisor | Type and timing of outcome assessment | Safety | Adherence |
---|---|---|---|---|---|---|---|
Sacre et al., 2014 [35] | Low risk for ineffectiveness | Low risk for ineffectiveness | Low risk for ineffectiveness | Low risk for ineffectiveness | Low risk for ineffectiveness | No details (probably done) | Low risk for ineffectiveness |
Bonhof et al., 2022 [38] | Low risk for ineffectiveness | Low risk for ineffectiveness | Low risk for ineffectiveness | No details (probably done) | Low risk for ineffectiveness | No details (probably done) | No details (probably done) |
Bhati et al., 2023 [39] | Low risk for ineffectiveness | Low risk for ineffectiveness | Low risk for ineffectiveness | Low risk for ineffectiveness | Low risk for ineffectiveness | No details (probably done) | No details (probably done) |